In a report released today, Ami Fadia from Needham reiterated a Buy rating on Revolution Medicines, with a price target of $145.00. The company’s shares closed last Friday at $96.43. According to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Microsoft Security Response Center has confirmed that a SQL Server elevation of ...
YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Tuesday reported net income of $27 million in its fourth quarter. The Yokneam, Israel-based company said it had net income of 42 ...
YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will ...
InMode Ltd. (NASDAQ:INMD) Q1 2025 Earnings Call Transcript April 28, 2025 Operator: Good day, and welcome to InMode's First Quarter 2025 Earnings Results Conference Call. All participants will be in ...
Jan 28 (Reuters) - Investment firm Steel Partners said on Wednesday it had offered $18 per share to acquire a 51% stake in InMode (INMD.O), opens new tab, sending the Israel-based medical technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results